Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Villa E, Moles A, Ferretti I, Buttafoco P, Grottola A, Del Bvono MG, De Santis M and Manenti F (2000) Natural history of inoperable hepatocellular carcinoma: estrogen receptor status in the tumor is the strongest prognostic factor for survival. Hepatology 32: 233–238
Villa E, Ferretti I, Grottola A, Buttafoco P, Del Bvono MG, Giannini F, Mannom,, Bertani H, Dugani A and Manenti F (2001) “Hormonal therapy with Megestrol in inoperable hepatocellular carcinoma characterised by variant estrogen receptors: a prospective, randomised, controlled trial”. Br J Cancer 84: 881–885
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Villa, E., De Maria, N., Colantoni, A. et al. Reply. Br J Cancer 85, 1607–1608 (2001). https://doi.org/10.1054/bjoc.2001.2091
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2091